AMGEN TO PRESENT AT CITI'S 2025 GLOBAL HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at Citi's 2025 Global Healthcare Conference on December 3, 2025 at 1:45 p.m. ET.

Presenters are Peter Griffith, executive vice president and chief financial officer, and Jay Bradner, executive vice president of Research and Development. The presentation will be webcast live and available to media, investors and the public on Amgen's investor website, with the webcast archived for replay for at least 90 days.

THOUSAND OAKS, Calif., Nov. 24, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2025 Global Healthcare Conference at 1:45 p.m. ET on December 3, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, and Jay Bradner, executive vice president of Research and Development at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. 

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. 

For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads.

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media) 
Casey Capparelli, 805-447-1746 (investors)  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2025-global-healthcare-conference-302623658.html

SOURCE Amgen

FAQ

When will Amgen (AMGN) present at Citi's 2025 Global Healthcare Conference?

Amgen will present on December 3, 2025 at 1:45 p.m. ET.

Who will represent Amgen (AMGN) at the December 3, 2025 Citi conference?

Peter Griffith (EVP & CFO) and Jay Bradner (EVP, R&D) will present.

Where can investors watch the Amgen (AMGN) webcast for the Citi conference?

The webcast will stream live on Amgen's investor website under Investors > Events.

How long will Amgen's (AMGN) Citi conference webcast remain available for replay?

The webcast will be archived and available for replay for at least 90 days after the event.

Will Amgen's (AMGN) Citi presentation be available to the general public and media?

Yes. The webcast will be broadcast simultaneously to the news media, investors and the general public.

Where can I find presentation times and webcast links for Amgen (AMGN) investor events?

Presentation times and webcast links are listed on Amgen's Investor Relations Events Calendar on its website.